Sinusitis :: Accentia issues update on blinded results in phase 3 of SinuNase for chronic sinusitis

Based on an interim blinded analysis of the first group of the more than 80 patients who have now completed the trial at 16 weeks, the study has shown improvement in polyposis by endoscopy in about 50 percent of patients (N=43) and improvement in sinus inflammation by CT scan in approximately 50 percent of patients (N=23). Moreover, 50 percent of patients with objective evidence of improvement have achieved the primary endpoint of complete resolution of cardinal symptoms.

Lung :: FDA approves Letairis for Treatment of Pulmonary Arterial Hypertension

The U.S. Food and Drug Administration (FDA) approved Letairis (ambrisentan) for the treatment of pulmonary arterial hypertension, a rare, life-threatening condition characterized by continuous high blood pressure within the arteries of the lungs.

Asthma :: Antibiotic use in infants linked to asthma

New research indicates that children who receive antibiotics before their first birthday are significantly more likely to develop asthma by age 7. The study, published in the June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), reports that children receiving antibiotics in the first year of life were at greater risk for developing asthma by age 7 than those not receiving antibiotics.

Healthcare :: High rate of health concerns among Iraq and Afghanistan war veterans

Veterans returning from Iraq and Afghanistan have a wide range of health concerns, including a 55 percent prevalence of mental health issues, reports a study in the May Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

Sinusitis :: NIAID supports research into etiology of fungal-induced inflammation in chronic sinusitis

Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI; Accentia) reports that the Mayo Medical and Graduate Schools and the Virginia Bioinformatics Institute have been awarded a National Institute of Health (NIH) grant of $2.4 million for a project entitled “The Pathogenesis of Chronic Rhinosinusitis.”

Asthma :: Survey shows asthma not controlled in majority of patients

A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly.

Sinusitis :: NIH awards VBI, Mayo Clinic $2.4M to study chronic rhinosinusitis

Virginia Bioinformatics Institute and Virginia Tech biological sciences associate professor Chris Lawrence is teaming up with Mayo Clinic on a $2.4 million project funded by the National Institute of Allergy and Infectious Diseases (NIAID). The work could help researchers develop treatments, diagnostic tools, and preventative measures for patients suffering from chronic rhinosinusitis (CRS).